1,3-Butadiene is used in the manufacture of synthetic rubbers (such as styrene-butadiene rubber or poly-butadiene rubber) and thermoplastic resins (1) . Approximately 3000 million pounds of butadiene are produced in the United States each year (2) . NIOSH estimates that approximately 9500 workers in the United States are occupationally exposed to 1,3-butadiene (1) .
The International Agency for Research on Cancer (IARC) reviewed the literature on butadiene in 1992 and concluded that there is "limited evidence" of the carcinogenicity of butadiene in humans and "sufficient evidence" of the carcinogenicity of butadiene in experimental animals based on three long-term animal bioassays (3) . Epidemiologic studies have been conducted among workers exposed to butadiene in the manufacture of styrene-butadiene rubber (4-) and among workers involved in the production of butadiene monomer (8) (9) (10) . Meinhardt et al. (4, 5) examined mortality among 2756 white males employed in two styrene-butadiene rubber production facilities in Port Neches, Texas. Elevated, although not statistically significant, increased mortality was observed for lymphatic and hematopoietic neoplasms at one of the two plants [standardized mortality ratio (SMR) = 155], in particular lymphosarcoma and reticulosarcoma (SMR = 181) and leukemia (SMR = 203). These excesses were most pronounced among workers hired during World War II. Matanoski et al. (6) analyzed the mortality experience of 13,920 rubber production workers in the United States and Canada and found no significant increase in mortality from lymphatic or hematopoietic cancer, or any other cancer site. However, a nonsignificant excess risk of "other lymphatic cancer" (SMR = 202) was noted among production workers. An update of this study was reported by Matanoski et al. in 1990 (7) . As in the earlier study, there was no significant increase in lymphatic or hematopoietic cancer, or any other cancer site. Production workers had a significant excess of "other lymphatic cancer" (SMR = 260). A significant excess of all lymphopoietic cancers was noted for blacks (SMR = 507). A nested case-control study of lymphopoietic cancer was conducted within this cohort. This study examined lymphopoietic cancer risk in relation to indices of cumulative butadiene and styrene exposure, and found a significant excess risk of leukemia associated with butadiene exposure (11) .
Only one previous study has examined the mortality experience of butadiene production workers (8) (9) (10) . This study included 2586 male workers employed at a facility located in Port Neches, Texas, for at least 6 months between 1943 and 1979. Butadiene was produced by the catalytic dehydrogenation of n-butane. The first analysis of the cohort by Downs et al. found eight deaths from lymphosarcoma and reticulosarcoma, yielding a significant SMR of 235 compared to national rates; the SMR was 185 and nonsignificant compared to county rates. In the update by Divine et al. (9) , there was one additional lymphosarcoma and reticulosarcoma death yielding a significant SMR of 229 (CI = 104-435; county-based SMR's were not reported). In a third update (10), the SMR for lymphosarcoma and reticulosarcoma in the total cohort was not significant (n = 9; SMR = 209; 95% CI = 95-396). However, among the subset of 1056 workers with routine exposure to 1,3-butadiene, there were 6 deaths from lymphosarcoma and reticulosarcoma (SMR = 452; 95% CI = 165-984).
To investigate the carcinogenic effects of exposure to butadiene in humans, a cohort of workers employed in butadiene units was identified from within a large cohort (29, 139 workers) of chemical workers whose mortality experience has previously been reported (12) . Rinsky et al. analyzed the mortality experience of the overall cohort without regard to particular exposures (12) . The primary hypothesis of the current study was that exposure to butadiene is associated with excess mortality from malignant neoplasms of the lymphatic and hematopoietic tissue. A secondary hypothesis was that butadiene would cause excess mortality from neoplasms of other sites.
Background
The study population was . The butadiene production process at South Charleston involved the recovery of butadiene monomer from olefin cracking (see appendix for process description). Among the chemicals used in the process was bis(2-chloroethyl)ether, which also has been evaluated by IARC for carcinogenicity. The IARC regards bis(2-chloroethyl)ether as having limited evidence of carcinogenicity in animals (13, 14) , based on a bioassay in which an excess of hepatomas was observed in mice (15) . This chemical showed negative results in a bioassay measuring pulmonary tumor response in mice (16) and in a long-term bioassay in rats (17) .
Rubber Reserve Unit, Institute plant (1943) (1944) (1945) (1946) (18) based on its ability to induce tumors of the larynx and nasal epithelium in hamsters (19) and rats (20) .
Institute plant (1959) (1960) (1961) (1962) (1963) (1964) (1965) (1966) (1967) (1968) (1969) (1970) (1971) (12) . The computer file of work history records contained a code representing each department in which an individual worked, but not the starting or ending dates. A total of 527 individuals were identified as having ever worked in the department codes relating to the butadiene units in the South Charleston or Institute plants identified for study. Copies of personnel records were collected for these individuals, and the starting and ending dates of their employment in each department were coded. Only 364 individuals who worked in the departments during the years when butadiene was produced were retained in the study (n = 364). As in the overall Kanawha Valley chemical workers cohort, there was a high proportion of individuals whose race was unknown (28%). Among those whose race was known, 94% were white. Therefore, individuals whose race was unknown were assumed to be white.
The Rinsky et al. (12) (21, 22 4.,'.
-I- SMR, standarized mortality ratio. because it was present in the rubber reserve process and because two of the four individuals who died of lymphosarcoma and reticulosarcoma worked in the acetaldehyde unit. In addition, a case-control study of risk factors for lymphopoietic cancer within Union Carbide's Kanawha Valley chemical plant (28) found an elevated odds ratio for non-Hodgkin's lymphoma associated with exposure to acetaldehyde, but noted that odds ratios and duration trends were similar for acetaldehyde and acrylonitrile because of concomitant use of the two chemicals.
To examine further whether the risk of lymphosarcoma and reticulosarcoma might be attributable to an elevated risk associated with the acetaldehyde unit, to which two of the four cases had been assigned, we identified 233 workers from the large cohort of 29, 139 who had ever been assigned to this unit and followed their mortality through 1991. A total of 48 deaths were identified. Aside from the two deaths from lymphosarcoma and reticulosarcoma previously identified among workers who had been included in the butadiene production study, there were no other deaths from this cause.
The toxicologic data are consistent with the conclusion that the excess of lymphosarcoma and reticulosarcoma found in the study are likely to be related to butadiene rather than confounding exposure to acetaldehyde. Acetaldehyde has only been demonstrated to induce upper respiratory tumors in rodents at levels (1000 ppm and above) substantially above the levels at which acetaldehyde has been demonstrated to cause eye irritation in humans (29) . In contrast, butadiene has been shown to cause an increase in incidence of lymphocytic lymphomas and histiocytic sarcomas in mice (formerly known as type A reticulum cell sarcomas) at concentrations as low as 200 ppm, with marginally signifiVolume 103, Number 6, June 1995 601 a"Dowtherm," "Ucon," "Heat transfer fluid 500," butyl hydroxy toluene, "Super floss" and "Vazo." Products were various grades of homopolymers and copolymers, recovered vinyl acetate, unreacted ethylenes, and oils.
bGas plants/olefins: Materials handled in this department included butane, propane, acetone, gasoline, butadiene vent gas, methanol, blowbacks from ethylene absorbers at "MB," polyethylene, chlorohydrin, propylene absorbers from isopropanol, caustic 20%, anti-oxidant, "DuPont No. 5," wood chips, and alumina pellets. Products included ethylene, propylene, and acetylene. By-products included crude butadiene, propane, "pyrofax," benzene, hydrogen methane, sulfur saturated wood chips, hydrogen, and residues.
cant increases in histiocytic sarcomas down to 20 ppm (24, 25) . When studying workers employed at large chemical production complexes, it is impossible to rule out the potential importance of confounding exposures. Ott et al. (28) noted that the average production worker at these plants was exposed to 58 different chemicals, many of which were correlated. Other studies conducted in the same chemical worker population have identified associations of lymphosarcoma and reticulosarcoma with maintenance (Teta J, unpublished data) and strong acid ethanol production (30) , and the broader category non-Hodgkin's lymphoma with units using acetaldehyde (28) . These observations were made in efforts to investigate the observed excess of death for the original cohort study of 29,139 workers or in surveillance studies. The current study, on the other hand, was initiated in 1986 to examine the hypothesis that exposure to butadiene might be related to hematopoietic cancer. If exposure data were available, the association between mortality from lymphosarcoma and reticulosarcoma might be evaluated by determining whether there is evidence for an exposure-response relationship. However, there are no air monitoring data for any of the butadiene production processes, and thus air concentrations of butadiene (and other chemicals) cannot be estimated. Personnel records do not indicate the types of tasks or job assignments an individual worker had; thus, there is no way to know whether the four individuals who developed lymphosarcoma or reticulosarcoma were exposed to higher concentrations of butadiene than other members of the cohort. Finally, the U.S. Rubber Reserve plant operated for only 4 years, and thus we could not evaluate the effects of prolonged exposure to this process.
Despite the limitations outlined above, the study has demonstrated an excess of mortality from lymphosarcoma and reticulosarcoma, which is consistent with the only other butadiene production cohort previously studied. Finding an excess of neoplasms of the lymphatic system in relation to butadiene exposure is consistent with the mouse bioassay data as well (18, 19 The rubber reserve plant was operated by the Union Carbide Corporation during World War II under contract with the U.S. government. The rubber reserve process produced butadiene indirectly from ethanol. To better understand the process, the plant may be considered as being composed of four major divisions: 1) an acetaldehyde conversion system, 2) a butadiene conversion system, 3) a butadiene purification system, and 4) a recovery distillation system.
In the acetaldehyde conversion system, the ethanol was introduced into a catalytic converter containing a copper-chromium catalyst and was partially converted to acetaldehyde. The The major process steps in the purification phase were as follows: 1) stripping the crude butadiene from the condensed liquids of the butadiene converters, 2) removal of acetaldehyde from the butadiene, and 3) removal of butane and butylene from the butadiene.
The crude butadiene was removed from the condensate collected from the catalytic converter by distillation in a heated column. The crude butadiene at this point is a mixture of butenes, butane, and the binary azeotrope of butadiene and acetaldehyde. The crude mixture, including the azeotrope with acetaldehyde, was passed through a water scrubber to absorb the acetaldehyde present in the vapor. The acetaldehyde-free vapor from the scrubber was then fed to another column and the butadiene was absorbed by Chlorex (di-2-chloroethyl ether). The Chlorex preferentially absorbed the butadiene and allowed the butylenes and butane to pass out of the column. The remaining vapors consisted largely of butadiene, water, and some Chlorex. Chlorex, when heated, breaks down and forms dilute hydrochloric acid. Caustic soda was used in the solvent system to neutralize the hydrochloric acid. The final step in the purification process required the water and the Chlorex to be condensed and separated. The resulting product is butadiene at a purity of 99.5%.
The function of the recovery distillation system was to reconcentrate the unreEnvironmental Health Perspectives 602 ESE M* *** acted acetaldehyde and ethanol from the conversion system, remove the by-products from the material cycle and to feed the converters.
Union Carbide Process: Recovery of Butadiene from Olefin Cracking (Institute Plant, 1959 -1971 and South Charleston Plant, The Union Carbide olefin unit used a high-temperature cracking process to produce ethylene from hydrocarbons. The process was developed to recover butadiene as a by-product of the normal ethylene process. The relatively pure mixture of the four carbon molecules (less than 50% butadiene) was supplied from three sources in 10,000-gallon capacity feed tanks.
Crude feed from the feed tanks was fed to an absorber column, and Chlorex was the solvent used to desorb the butadiene. The Chlorex, after absorption of the majority of the butadiene, was routed to a stripping column. The crude butadiene at this phase of the process was 88-90% pure. The material was then scrubbed with water to remove any aldehydes which might have been present. The condensed, partially refined butadiene was then compressed and piped to the 10,000-gallon capacity intermediate storage tanks prior to recracking. To control the formation of popcorn-type polymers, sodium nitrite was added to the process stream to remove the oxygen.
Final refining of butadiene was a distillation process carried out in a two-column system. The 88-90% butadiene stream was introduced to a fore column where vinyl acetylene was removed from the process stream. The butadiene was now 97% pure and final purity of 99.5% was obtained from the refined butadiene condenser and then pumped to the refined storage tanks. Before loading or shipping the final product, Catechol (p-tertiary butyl catechol) was injected into the product to inhibit polymerization.
Subsequent process changes, 1965 and later, used dimethyl acetamide as the absorbent solvent in place of Chlorex.
